Citations

Showing 10 of 108104 citations.

The Basic Four Approach to Clinical Neuroscience Instruction: Using Cognitive Load Theory to Enhance Case-based Learning
Sunde, Kiri, Cutsforth‐Gregory, Jeremy K. , Sunde, Kiri E., Leep Hunderfund, Andrea N, Hunderfund, Andrea N. Leep

Mayo Clinic

Journal of Medical Education and Curricular Development | December 26, 2018 | Volume: 5 | Issue: No issue available | Pages: No page available

10.1177/2382120518815698 | PMID 30627673 Get It

Among medical students, neurosceince is considered a notoriously difficult subject. This challenges faculty to teach preclinical neurology in more engaging, efficient, and prioritized ways. Traditional approaches to neuroscience instruction typically begin with neuroanatomy and advance to clinical problem solving after this foundation of knowledge is in place. Over the past 45 years, neurology faculty at Mayo Clinic Alix School of Medicine have developed and iteratively refined an inverted approach called The Basic Four. The Basic Four uses authentic clinical scenarios as the basis for neuroscience instruction and incorporates principles from cognitive load theory to calibrate load on students’ working memory. This perspective describes The Basic Four and illustrates how cognitive load theory can be used to enhance case-based learning.
Episodic ataxia in CASPR2 autoimmunity
López‐Chiriboga, A. Sebastian , Pittock, Sean J. , Pittock, S J

Mayo Clinic

Neurology Neuroimmunology & Neuroinflammation | December 25, 2018 | Volume: 6 | Issue: 2 | Pages: No page available

10.1212/nxi.0000000000000536 | PMID 30697586 Get It

Less Than Ideal
Lin, Amy , Markovic, Daniela , Ovbiagele, Bruce , Sanossian, Nerses , Lin, Michelle P, Lin, Amy M., Lin, Michelle , Ovbiagele, Bruce , Towfighi, Amytis

Mayo Clinic

Stroke | December 24, 2018 | Volume: 50 | Issue: 1 | Pages: 5-12

10.1161/strokeaha.118.022644 | PMID 30580724 Get It

Background and Purpose— The American Heart Association’s Life’s Simple 7 (LS7) defines ideal cardiovascular health by 7 metrics: not smoking, regular physical activity, normal body mass index, blood pressure, plasma glucose, and total cholesterol levels, and a healthy diet. We assessed prevalence and predictors of ideal LS7 among US stroke survivors. Methods— Among 67 514 participants in the National Health and Nutrition Examination Surveys from 1988 to 1994 and 1999 to 2014, 1597 adults (≥18 years) had self-reported history of stroke. LS7 metrics were categorized as poor, intermediate, and ideal; ideal LS7 scores were calculated (1 point for each ideal metric met). Trends in poor, intermediate, and ideal cardiovascular health were assessed. Odds of low (0–1) versus high (≥4) ideal LS7 scores were assessed according to sex, race, poverty income ratio, and education level, before and after adjusting for covariates. Results— Only 1 participant met all ideal LS7 metrics. The proportion with low LS7 score increased from 17.9% in 1988 to 1994 to 35.4% in 2011 to 2014 ( P <0.001). Over that time frame, prevalence of poor blood pressure (≥140/90 mm Hg) and poor cholesterol (≥240 mg/dL) decreased (45.2%–26.5% and 37.2%–10.3%), whereas prevalence of poor body mass index (≥30 kg/m 2 ), poor diet (healthy eating index score <50), and poor physical activity (0 minutes moderate/vigorous activity per week) increased (26.9%–39.0%; 14.2%–50.6%; 44.6%–70.9%; all P <0.05). After adjustment, black race (odds ratio, 2.29; 95% CI, 1.17–4.48), poverty income ratio ≤200% (odds ratio, 2.20, 95% CI, 1.11–4.36), and ≤12th grade education (odds ratio, 4.50; 95% CI, 2.27–8.92) were associated with low ideal LS7 scores. Conclusions— Over the past 3 decades, blood pressure and cholesterol control among stroke survivors improved, but rates of obesity, poor diet, and physical inactivity increased. Stroke survivors who are black, poor, or less educated are less likely to have ideal cardiovascular health.
Computed Tomography Technology—and Dose—in the 21st Century
McCollough, Cynthia H.

Mayo Clinic

Health Physics | December 24, 2018 | Volume: 116 | Issue: 2 | Pages: 157-162

10.1097/hp.0000000000000997 | PMID 30585957 Get It

AbstractIn the last decade or so, a number of disruptive technological advances have taken place in x-ray computed tomography, making possible new clinical applications. Changes in scanner design have included the use of two x-ray sources and two detectors or the use of large detector arrays that provide 16 cm of longitudinal coverage in one gantry rotation. These advances have allowed images of the entire heart to be acquired in just one heartbeat, lowering the effective dose from cardiac computed tomography from ~15 mSv to <1 mSv. Dual-energy computed tomography is now in widespread clinical use, enabling the assessment of material composition and concentration, as well as a range of new clinical applications. An emerging technology known as photon-counting detector computed tomography directly measures the energies of detected photons and is capable of simultaneously acquiring more than two energy data sets. Photon-counting detector computed tomography also provides advantages such as the ability to reject electronic noise, better iodine contrast-to-noise for a given dose, and spatial resolution as fine as 150 μm. Optimized x-ray tube potential selection has allowed reduction in radiation and contrast doses. Finally, wide adoption of iterative reconstruction and noise-reduction techniques has occurred. In all, body computed tomography doses have fallen dramatically, for example, by over a factor of 3 from the early 1980s. All of these advances increase the medical benefit and decrease the potential radiation risk associated with computed tomography. However, care must be taken to ensure that doses are not lowered to the level at which the clinical task is compromised.
Voice outcomes following medialization laryngoplasty with and without arytenoid adduction
Zimmermann, Terence M., Orbelo, Diana M. , Pittelko, Rebecca L. , Youssef, Stephanie J. , Lohse, Christine M. , Ekbom, Dale C. , Orbelo, Diana

Mayo Clinic

The Laryngoscope | December 24, 2018 | Volume: 129 | Issue: 8 | Pages: 1876-1881

10.1002/lary.27684 | PMID 30582612 Get It

ObjectiveVoice outcomes following medialization laryngoplasty (ML) for unilateral vocal fold paralysis (UVFP) were compared to those who underwent ML plus arytenoid adduction (AA) (ML+AA).MethodsSingle institution retrospective review of patients with UVFP undergoing ML and ML+AA (2009–2017). Demographic information and history of laryngeal procedures were collected. Preoperative and postoperative Voice Handicap Index‐10 (VHI‐10) and Consensus Perceptual Auditory Evaluation of Voice (CAPE‐V) were assessed.ResultsOf 236 patients, 119 met study criteria. Of those, 70 (59%) underwent ML and 49 (41%) underwent ML+AA. Significant differences between groups at baseline were found for age at time of thyroplasty (P = 0.046), VHI‐10 scores (P < 0.001), and CAPE‐V scores (P = 0.007). Baseline VHI‐10 scores for ML+AA (28 ± 7) were greater than those for ML alone (24 ± 7). At 12 months, overall VHI‐10 scores improved compared to baseline for both groups (ML+AA = 9 ± 7, ML = 16 ± 9); however, there was greater improvement for the ML+AA group compared to ML group (P = 0.001). CAPE‐V scores at 3 or 12 months improved, but differences between the groups were not statistically significant once controlled for covariates.ConclusionBased on current findings, patients who undergo ML+AA likely have greater voice handicap at baseline compared to those undergoing ML alone. Patients selected for ML+AA improve as much or more than those who underwent ML alone. This highlights the importance of appropriate selection of candidates for AA.Level of Evidence4Laryngoscope, 129:1876–1881, 2019
CHA 2 DS 2 -VASc Score and Stroke Prediction in Atrial Fibrillation in Whites, Blacks, and Hispanics
Norby, Faye L. , Chamberlain, Alanna M. , MacLehose, Richard F. , Bengtson, Lindsay G.S. , Lutsey, Pamela L. , Chamberlain, Alanna M , Lutsey, Pamela L , Chen, Lin Y. , Alonso, Álvaro

Mayo Clinic

Stroke | December 24, 2018 | Volume: 50 | Issue: 1 | Pages: 28-33

10.1161/strokeaha.118.021453 | PMID 30580712 Get It

Background and Purpose— Despite modest predictive ability for ischemic stroke (IS), the CHA 2 DS 2 -VASc score is widely used for stroke prediction in atrial fibrillation. Among patients with atrial fibrillation, we aimed to (1) compare the IS or transient ischemic attack (TIA) incidence by CHA 2 DS 2 -VASc in blacks and Hispanics versus whites; (2) compare predictive ability of CHA 2 DS 2 -VASc score for IS or TIA in blacks and Hispanics versus whites; and (3) determine improvement in predictive ability of CHA 2 DS 2 -VASc score from addition of race/ethnicity. Methods— Using data from Optum Clinformatics, a large administrative claims database, we analyzed patients with atrial fibrillation enrolled in commercial and Medicare Advantage health plans from 2009 to 2015. We computed IS or TIA incidence rates, improvement in C statistic, continuous and categorical net reclassification improvement, and relative integrated discrimination improvement from addition of race/ethnicity to CHA 2 DS 2 -VASc. Results— A total of 267 419 patients (mean age, 73.1 [SD, 12.3] years; 46.6% women; 84.2% white, 8.5% black, 7.3% Hispanic) were studied. After a mean follow-up of 22 months, there were 6202 IS or TIA events. IS or TIA incidence rates were higher in blacks than Hispanics or whites (1.65, 1.40, and 1.22 cases per 100 person-years, respectively) and increased with higher CHA 2 DS 2 -VASc, with no race/ethnicity-based differences ( P for interaction=0.17). The CHA 2 DS 2 -VASc and CHA 2 DS 2 -VASc+race/ethnicity C statistic (95% CI) were 0.679 (0.670–0.686) and 0.679 (0.671–0.688). The CHA 2 DS 2 -VASc C statistic in the 3 groups were comparable. With addition of race/ethnicity, the categorical net reclassification improvement, continuous net reclassification improvement, and relative integrated discrimination improvement were −0.045 (95% CI, −0.067 to −0.025), 0.045 (95% CI, 0.025–0.068), and 0.016 (95% CI, 0.014–0.018). Conclusions— The predictive ability of CHA 2 DS 2 -VASc for IS or TIA in atrial fibrillation is comparable among whites, blacks, and Hispanics; hence, it can be used in the latter 2 groups. Addition of race/ethnicity to the CHA 2 DS 2 -VASc does not improve its predictive ability.
History and Justification of a National Blood Pressure Measurement Validated Device Listing
Cohen, Jordana B. , Padwal, Raj , Gutkin, Michael , Bloch, Michael J. , Germino, F. Wilford, Sica, Domenic A., Viera, Anthony J. , Bluml, Benjamin M. , White, William B. , Taler, Sandra J. , Yarows, Steven A. , Green, Beverly B. , Shimbo, Daichi , Townsend, Raymond R.

Mayo Clinic

Hypertension | December 24, 2018 | Volume: 73 | Issue: 2 | Pages: 258-264

10.1161/hypertensionaha.118.11990 | PMID 30580681 Get It

The Role of Three‐Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery
Shah, Vijay H. , Therneau, Terry M. , Venkatesh, Sudhakar K. , Mounajjed, Taofic, Larson, Joseph J. , Mara, Kristin C. , Schulte, Phillip J. , Kellogg, Todd A., Kendrick, Michael L. , McKenzie, Travis J. , Greiner, Suzanne , Li, Jiahui , Glaser, Kevin J. , Wells, Michael , Yin, Meng , Greiner, Suzanne M, Wells, Michael L, Venkatesh, Sudhakar K , Mara, Kristin C , Yin, Meng , Allen, Alina M. , Chen, Jun , Ehman, Richard L. , Li, Jiahui

Mayo Clinic

Hepatology | December 24, 2018 | Volume: 71 | Issue: 2 | Pages: 510-521

10.1002/hep.30483 | PMID 30582669 Get It

The lack of reliable, noninvasive methods to diagnose early nonalcoholic steatohepatitis (NASH) is a major unmet need. We aimed to determine the diagnostic accuracy of three‐dimensional magnetic resonance elastography (3D‐MRE), with shear stiffness measured at 60 Hz, damping ratio at 40 Hz, and magnetic resonance imaging proton density fat fraction (MRI‐PDFF) in the detection of NASH in individuals undergoing bariatric surgery. Obese adults at risk for NASH were enrolled between 2015 and 2017 (prospective cohort, n = 88) and 2010 and 2013 (retrospective cohort, n = 87). The imaging protocol consisted of multifrequency 3D‐MRE (mf3D‐MRE) with shear waves delivered at different frequencies to explore parameters that best correlated with histologic NASH, and MRI‐PDFF to estimate steatosis. The prospective cohort was used to establish the optimal mf3D‐MRE technical parameters for NASH detection. The two cohorts were then combined to derive predictive models of NASH and disease activity by nonalcoholic fatty liver disease activity score (NAS) using the three imaging parameters that correlated with NASH. A total of 175 patients (median age 45, 81% women, and 81 [46%] with histologic NASH) were used for model derivation. From the complex shear modulus output generated by mf3D‐MRE, the damping ratio at 40 Hz and shear stiffness at 60 Hz best correlated with NASH. The fat fraction obtained from MRI‐PDFF correlated with steatosis ( P < 0.05 for all). These three parameters were fit into a logistic regression model that predicted NASH with cross‐validated area under the receiver operating characteristic curve (AUROC) = 0.73, sensitivity = 0.67, specificity = 0.80, positive predictive value = 0.73 and negative predictive value = 0.74, and disease activity by NAS with cross‐validated AUROC = 0.82. Conclusion: The mf3D‐MRE allows identification of imaging parameters that predict early NASH and disease activity. This imaging biomarker represents a promising alternative to liver biopsy for NASH diagnosis and monitoring. The results provide motivation for further studies in nonbariatric cohorts.
Should pretest genetic counselling be required for patients pursuing genomic sequencing? Results from a survey of participants in a large genomic implementation study
Pacyna, Joel E. , Breitkopf, Carmen Radecki , Jenkins, Sarah M. , Sutton, Erica J., Horrow, Caroline , Sharp, Richard R. , Sharp, Richard R , Kullo, Iftikhar J.

Mayo Clinic

Journal of Medical Genetics | December 22, 2018 | Volume: 56 | Issue: 5 | Pages: 317-324

10.1136/jmedgenet-2018-105577 | PMID 30580287 Get It

Purpose We assessed the decision-making of individuals pursuing genomic sequencing without a requirement for pretest genetic counselling. We sought to describe the extent to which individuals who decline genetic counselling reported decisional conflict or struggled to make a decision to pursue genomic testing. Methods We administered a 100-item survey to 3037 individuals who consented to the Return of Actionable Variants Empirical study, a genomic medicine implementation study supported by the National Institutes of Health (USA) eMERGE consortium. The primary outcomes of interest were self-reported decisional conflict about the decision to participate in the study and time required to reach a decision. Results We received 2895 completed surveys (response rate=95.3%), and of these respondents 97.8% completed the decisional conflict scale in its entirety. A majority of individuals (63%) had minimal or no decisional conflict about the pursuit of genomic sequencing and were able to reach a decision quickly (78%). Multivariable logistic regression analyses identified several characteristics associated with decisional conflict, including lower education, lower health literacy, lower self-efficacy in coping, lack of prior experience with genetic testing, not discussing study participation with a family member or friend, and being male. Conclusion As genomic sequencing is used more widely, genetic counselling resources may not be sufficient to meet demand. Our results challenge the notion that all individuals need genetic counselling in order to make an informed decision about genomic sequencing.